- § 391. Separability clause
- § 392. Exemption of meats and meat food products
- § 393. Food and Drug Administration
- § 393a. Office of Pediatric Therapeutics
- § 394. Scientific review groups
- § 395. Loan repayment program
- § 396. Practice of medicine
- § 397. Contracts for expert review
- § 398. Notices to States regarding imported food
- § 399. Grants to enhance food safety
- § 399a. Office of the Chief Scientist
- § 399b. Office of Women’s Health
- § 399c. Improving the training of State, local, territorial, and tribal food safety officials
- § 399d. Employee protections
- § 399e. Nanotechnology
- § 399f. Ensuring adequate information regarding pharmaceuticals for all populations, particularly underrepresented subpopulations, including racial subgroups
- § 399g. Food and Drug Administration Intercenter Institutes
- § 399h. National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing
- § 399i. Food and Drug Administration Working Capital Fund
Quick search by citation:
21 U.S. Code Subchapter X - MISCELLANEOUS
prev | next
Editorial Notes
Codification
Former subchapter IX of this chapter was redesignated as this subchapter.